![Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism | Journal of Nuclear Medicine Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/8/1154/F1.large.jpg)
Kinetic Modeling of 18F-(2S,4R)4-Fluoroglutamine in Mouse Models of Breast Cancer to Estimate Glutamine Pool Size as an Indicator of Tumor Glutamine Metabolism | Journal of Nuclear Medicine
![Regression of Human Breast Carcinoma in Nude Mice After Adsflt Gene Therapy is Mediated by Tumor Vascular Endothelial Cell Apoptosis | bioRxiv Regression of Human Breast Carcinoma in Nude Mice After Adsflt Gene Therapy is Mediated by Tumor Vascular Endothelial Cell Apoptosis | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/07/19/2020.07.19.210856/F2.large.jpg)
Regression of Human Breast Carcinoma in Nude Mice After Adsflt Gene Therapy is Mediated by Tumor Vascular Endothelial Cell Apoptosis | bioRxiv
![Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine - ScienceDirect Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780128200162000136-f13-03-9780128200162.jpg)
Development in efficacy assessment in relevant oncology models for breast cancer nanomedicine - ScienceDirect
![JCI - Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss JCI - Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss](https://dm5migu4zj3pb.cloudfront.net/manuscripts/33000/33320/medium/JCI0833320.f3.jpg)
JCI - Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16Ink4a loss
![SciELO - Brasil - Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible SciELO - Brasil - Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible](https://minio.scielo.br/documentstore/1678-7765/vrSxDVsb7jmpmvVhSC6krZq/54242e1ac1a3e01677d525f1e3f49747eedb8e49.png)
SciELO - Brasil - Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible
![Morin reduces breast cancer cell growth in a mouse model in vivo (A)... | Download Scientific Diagram Morin reduces breast cancer cell growth in a mouse model in vivo (A)... | Download Scientific Diagram](https://www.researchgate.net/publication/263746873/figure/fig4/AS:296468222103554@1447694940350/Morin-reduces-breast-cancer-cell-growth-in-a-mouse-model-in-vivo-A-Survival-curves-of.png)
Morin reduces breast cancer cell growth in a mouse model in vivo (A)... | Download Scientific Diagram
![A murine preclinical syngeneic transplantation model for breast cancer precision medicine | Science Advances A murine preclinical syngeneic transplantation model for breast cancer precision medicine | Science Advances](https://www.science.org/cms/10.1126/sciadv.1600957/asset/21efb798-a8cb-40a1-ae23-a236c7e5e852/assets/graphic/1600957-f1.jpeg)
A murine preclinical syngeneic transplantation model for breast cancer precision medicine | Science Advances
![Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation - ScienceDirect Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124716311299-fx1.jpg)
Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation - ScienceDirect
![NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers | Science Advances NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers | Science Advances](https://www.science.org/cms/10.1126/sciadv.abc8145/asset/187bf235-23bb-4de8-89bf-3cf6311ce65d/assets/images/large/sciadv.abc8145-f1.jpg)
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers | Science Advances
![Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors](https://www.spandidos-publications.com/article_images/or/33/1/OR-33-01-0179-g00.jpg)
Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors
![Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo | Oncogene Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo | Oncogene](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41388-020-01560-0/MediaObjects/41388_2020_1560_Fig2_HTML.png)